Tumor-lymphatic interactions in an activated stromal microenvironment

Journal of Cellular Biochemistry

Volumn 101, Issue 4, 2007, Pages 840-850

  Wong, Sunny Y ^a   Hynes, Richard O ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NONE   (United States)

Author keywords

Angiogenesis; Lymphangiogenesis; Metastasis; Microenvironment; Stroma

Indexed keywords

CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR CELL;

ANIMALS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; NEOPLASMS; STROMAL CELLS;

EID: 34447290271     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21146     Document Type: Review

References (71)

1. Achen MG, McColl BK, Stacker SA. 2005. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7:121-127.
2. Alitalo K, Mohla S, Ruoslahti E. 2004. Lymphangiogenesis and cancer: Meeting report. Cancer Res 64:9225-9229.
3. Alitalo K, Tammela T, Petrova TV. 2005. Lymphangiogenesis in development and human disease. Nature 438:946-953.
4. Bhowmick NA, Moses HL. 2005. Tumor-stroma interactions. Curr Opin Genet Dev 15:97-101.
5. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. 2004a. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-851.
6. Bhowmick NA, Neilson EG, Moses HL. 2004b. Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337.
7. Bissell MJ, Radisky D. 2001. Putting tumours in context. Nat Rev Cancer 1:46-54.
8. Brauchle M, Angermeyer K, Hubner G, Werner S. 1994. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9:3199-3204.
9. Carmeliet P, Collen D. 1998. Vascular development and disorders: Molecular analysis and pathogenic insights. Kidney Int 53:1519-1549.
10. Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK. 2005. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65:9004-9011.
11. Coussens LM, Werb Z. 2002. Inflammation and Cancer. Nature 420:860-867.
12. Crnic I, Strittmatter K, Cavallaro U, Kopfstein L, Jussila L, Alitalo K, Christofori G. 2004. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res 64:8630-8638.
13. Cunha GR, Hayward SW, Wang YZ, Ricke WA. 2003. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107:1-10.
14. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040-1050.
15. Eubank TD, Galloway M, Montague CM, Waldman WJ, Marsh CB. 2003. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J Immunol 171:2637-2643.
16. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B. 1998. Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725.
17. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. 2006. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 124:175-189.
18. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R. 2003. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3:589-601.
19. Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Oliver G, Jackson DG, Detmar M. 2002. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 21:7945-7956.
20. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. 2002. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor-3 signaling. J Natl Cancer Inst 94:819-825.
21. He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. 2004. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64:3737-3740.
22. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K. 2005. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739-4746.
23. Heldin CH, Rubin K, Pietras K, Ostman A. 2004. High interstitial fluid pressure - An obstacle in cancer therapy. Nat Rev Cancer 4:806-813.
24. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. 2005. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-1099.
25. Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M, Jalkanen S. 2001. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med 194:1033-1042.
26. Irjala H, Alanen K, Grenman R, Heikkila P, Joensuu H, Jalkanen S. 2003. Mannose receptor (MR) and common lymphatic enothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 63:4671-4676.
27. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J. 2006. Integrin alpha4-beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 66:2146-2152.
28. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827.
29. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80.
30. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, Krober SM, Greinix H, Rosenmaier A, Karlhofer F, Wick N, Mazal PR. 2006. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12:230-234.
31. Kim J, Yu W, Kovalski K, Ossowski L. 1998. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353-362.
32. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. 2004. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci 101:4966-4971.
33. LeBedis C, Chen K, Fallavollita L, Boutros T, Brodt P. 2002. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 100:2-8.
34. Lin EY, Nguyen AV, Russell RG, Pollard JW. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-739.
35. Lynch CC, Matrisian LM. 2002. Matrix metalloproteinases in tumor-host cell communication. Differentiation 70:561-573.
36. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682.
37. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Rooijen NV, Takenaka H, D'Amore PA, Stein-Streilen J, Losordo DW, Streilein JW. 2005. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363-2372.
38. McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA, Achen MG. 2003. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 198:863-868.
39. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
40. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. 1997. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 57:3305-3313.
41. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, Henderson A, Kerjaschki D, Maurer D, Graham GJ, Rot A. 2001. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 158:867-877.
42. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. 1999. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011.
43. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. 2004. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95:32-39.
44. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348.
45. Padera TP, Kadambi A, Tomaso Ed, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK. 2002. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883-1886.
46. Qian F, Hanahan D, Weissman IL. 2001. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci 98:3976-3981.
47. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.
48. Scapini P, Morini M, Tecchio C, Minghelli S, Carlo ED, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM, Cassatella MA. 2004. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol 172:5034-5040.
49. Schoppmann SF, Schindl M, Breiteneder-Geleff S, Soleiman A, Breitenecker G, Karner B, Birner P. 2001. Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervical cancer. Anticancer Res 21:3419-3424.
50. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947-956.
51. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J. 2003. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci 100:8430-8435.
52. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib AM. 2003. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 111:1723-1732.
53. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198.
54. Sleeman J. 2000. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157:55-81.
55. Soldi R, Mitola S, Strasly M, Defuippi P, Tarone G, Bussolino F. 1999. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18:882-892.
56. St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lai A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. 2000. Genes expressed in human tumor endothelium. Science 289:1197-1202.
57. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191.
58. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. 2002. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573-583.
59. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137-146.
60. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S. 2004. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5:79-90.
61. Tang Y, Zhang D, Fallavollita L, Brodt P. 2003. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res 63:1166-1171.
62. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. 2004. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731-3736.
63. Trompezinski S, Berthier-Vergnes O, Denis A, Schmitt D, Viac J. 2004. Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp Dermatol 13:98-105.
64. Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML. 2003. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278:5750-5759.
65. Vlahakis NE, Young BA, Atakilit A, Sheppard D. 2005. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 280:4544-4552.
66. Wang JF, Zhang XF, Groopman JE. 2001. Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J Biol Chem 276:41950-41957.
67. Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS. 2005. Tumor cells caught in the act of invading: Their strategy for enhanced cell motility. Trends Cell Biol 15:138-145.
68. Wiley HE, Gonzalez EB, Maki W, Wu M, Hwang ST. 2001. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638-1643.
69. Wong SY, Hynes RO. 2006. Lymphatic or hematogenous dissemination: How does a metastatic tumor cell decide? Cell Cycle 5:812-817.
70. Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. 200S. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 65:9789-9798.
71. Zhang X, Groopman JE, Wang JF. 2005. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol 202:205-214.